What is Mounjaro™ (tirzepatide)?
A once-weekly injectable medication approved by the FDA for type 2 diabetes, combining GIP and GLP-1 receptor agonist actions to improve glucose metabolism and support weight loss.
A once-weekly injectable medication approved by the FDA for type 2 diabetes, combining GIP and GLP-1 receptor agonist actions to improve glucose metabolism and support weight loss.